ProShares Ultra Health Care
$58.84−0.92 (−1.54%)
- Expense ratio
- 1.07%
- Fund size
- $98M
- 1Y return
- +47.1%
- Yield · Last 12 months
- 1.18%
- Holdings
- 70
- Volume · 30D
- 0M sh
- NAV per share
- $58.47
- 52W range
The ETF.net RXL Grade
Score 54 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.CScore 44Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 67Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.BScore 56Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.BScore 55Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 75Category rank
Our read on RXL
CThe 2x way to lean on health care. RXL doubles the daily move of the big health care sector index, roughly 70 drug, device and insurer names, and it has been doing that since 2007. The leverage resets every day.
The fund seeks daily returns, before fees and expenses, equal to two times the daily performance of the S&P Health Care Select Sector Index.
Why people hold it
- Aims for two times the daily performance of the S&P Health Care Select Sector Index: about 70 pharma, device and insurer stocks, not a single-name bet.proshares.com
- Double, not triple. The 2x mandate applies the same daily-reset machinery with less daily punch than 3x sector products.proshares.com
- Running since 2007, so the structure has operated through the financial crisis, COVID and several drug-pricing scares. Long tenure for a leveraged fund.
- Pays on a quarterly schedule, which is unusual company for a geared sector fund.
Worth knowing
- The 2x target is a daily one. Hold longer and compounding takes over: in choppy stretches, results can diverge meaningfully from twice the index move.
- A small fund that trades thinly, so bid-ask spreads can run wider than on the headline leveraged names.
- The 1.07% expense ratio sits a shade above the typical leveraged bull fund, and cheaper geared products exist on other sectors (FAS 0.92%, UYG 0.94%).
RXL Holdings
- Stocks
- 70
- 70%
- Net Other Assets (Liabilities)
Sectors
- Health Care80.9%
- Financials18.5%
- Technology0.5%
Geography
- United States98.09%
- Ireland1.91%
RXL Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | RXL |
|---|---|
| Year to date | +16.3% |
| 1 month | −5.4% |
| 3 months | +26.0% |
| 1 year | +47.1% |
| 3 years | +13.6% |
| 5 years | +4.2% |
| 10 years | +14.0% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | RXL |
|---|---|---|
| 2026 YTD | +16.3% | |
| 2025 | +19.8% | |
| 2024 | −2.7% | |
| 2023 | −3.2% | |
| 2022 | −15.3% | |
| 2021 | +48.1% | |
| 2020 | +19.2% |
RXL in the news
ETF.net Research hasn’t filed on RXL yet — coverage lands here as it’s written.
RXL Dividends
- 1.18%
- $0.71
- $0.18 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Jun 24, 2026 | Jun 30, 2026 | $0.18 |
| Mar 25, 2026 | Mar 31, 2026 | $0.14 |
| Dec 24, 2025 | Dec 31, 2025 | $0.18 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.22 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.15 |
| Sep 25, 2024 | Oct 2, 2024 | $0.13 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.09 |
| Dec 20, 2023 | Dec 28, 2023 | $0.08 |
| Dec 22, 2022 | Dec 30, 2022 | $0.11 |
RXL Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 28.6%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.39
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −36.1%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 1.04
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
RXL Cost
- The middle half of Leveraged Long (2x & Other) funds
- Median 0.99%
54 of the 93 Leveraged Long (2x & Other) funds charge less.